Racial, Ethnic Minorities With Parkinson Disease Have Worse HRQoL

2023-04-05
临床结果
WEDNESDAY, April 5, 2023 -- For patients with Parkinson disease (PD), racial and ethnic minorities have worse health-related quality of life (HRQoL) than White patients, according to a study published online April 5 in Neurology.
Daniel Garbin Di Luca, M.D., from the Krembil Brain Institute at Toronto Western Hospital, and colleagues conducted a retrospective cross-sectional and longitudinal cohort study of individuals to examine variability in HRQoL and other outcomes in patients with PD. Data were included for 8,514 participants with at least one recorded visit (90.2 percent self-identified as White, 5.81 percent as Hispanic, 2 percent as Asian, and 1.9 percent as African American).
The researchers found that the total 39-item PD questionnaire (PDQ-39) scores were significantly higher in African Americans, Hispanics, and Asians than in Whites (28.56, 26.62, and 25.43 versus 22.73) after adjustment. In most PDQ-39 subscales, this difference was also significant. The inclusion of cognitive scores in the longitudinal analysis significantly decreased the strength of the association of PDQ-39 with race/ethnicity for minority groups. Cognition partially mediated the association between race/ethnicity and PDQ-39 scores in a mediation analysis (proportion mediated, 0.251).
"Evaluating the underlying reasons behind differences in quality of life between racial and ethnic groups is crucial to improve care," Di Luca said in a statement. "Future studies are needed to gain a better understanding of the reasons for treatment and outcome differences in underrepresented populations, including differences in thinking and memory, clinical care, and quality of life."
Abstract/Full Text (subscription or payment may be required)
Posted April 2023
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。